Literature DB >> 7489177

Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive.

P Rougier1, C Milan, F Lazorthes, G Fourtanier, C Partensky, H Baumel, J Faivre.   

Abstract

Prognostic factors of unresected liver metastases in patients with colorectal cancer are not well established. A total of 544 patients with unresected liver metastases from colorectal cancer were registered in a national survey over a 1-year period and followed until death. Twenty factors were studied in a univariate analysis (log rank test) and 16 influenced survival (P < 0.01). These 16 factors were entered in a multivariate analysis (Cox model) and eight, ranging from the most significant (relative risk of death 1.9) to the less significant (relative risk of death 1.2), independently influenced survival: performance status, alkaline phosphatase level, number of involved liver segments, administration of chemotherapy, presence of extrahepatic metastases, site of the primary tumour, prothrombin time and resection of the primary lesion. Two simple classifications are proposed, taking into account the performance status and the alkaline phosphatase level, or the performance status and the number of involved liver segments.

Entities:  

Mesh:

Year:  1995        PMID: 7489177     DOI: 10.1002/bjs.1800821034

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  43 in total

1.  Combined hepatic resection with the inferior vena cava and diaphragm and reconstruction using an equine pericardial patch: report of a case.

Authors:  Koji Asai; Manabu Watanabe; Hiroshi Matsukiyo; Akihiro Osawa; Tomoaki Saito; Takaharu Kiribayashi; Toshiyuki Enomoto; Yoichi Nakamura; Yasushi Okamoto; Yoshihisa Saida; Shinya Kusachi; Toshiaki Oharaseki; Jiro Nagao
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

2.  Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Authors:  Wolfgang Peter Fendler; Harun Ilhan; Philipp M Paprottka; Tobias F Jakobs; Volker Heinemann; Peter Bartenstein; Feras Khalaf; Samer Ezziddin; Marcus Hacker; Alexander R Haug
Journal:  Eur Radiol       Date:  2015-02-28       Impact factor: 5.315

3.  Single-Centre Experience of Supra-Renal Vena Cava Resection and Reconstruction.

Authors:  Nikola Vladov; Radoslav Kostadinov; Vassil Mihaylov; Ivelin Takorov; Tsonka Lukanova; Maria Yakova; Tsvetan Trichkov; Evelina Odisseeva; Ventsislav Mutafchiyski
Journal:  World J Surg       Date:  2021-03-16       Impact factor: 3.352

4.  Resection and reconstruction of the inferior vena cava for neoplasms.

Authors:  Nikola Nikolov Vladov; Vassil Ivanov Mihaylov; Nikolai Vassilev Belev; Ventzislav Metodiev Mutafchiiski; Ivelin Rumenov Takorov; Sergei Kirilov Sergeev; Evelina Hristova Odisseeva
Journal:  World J Gastrointest Surg       Date:  2012-04-27

5.  Surgical management of colorectal liver metastases.

Authors:  Waleed M Mohammad; Fady K Balaa
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 6.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

Review 7.  Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.

Authors:  Aaron T Wild; Yoshiya Yamada
Journal:  Visc Med       Date:  2017-02-03

8.  Combined resection of the liver and inferior vena cava for hepatic malignancy.

Authors:  Alan W Hemming; Alan I Reed; Max R Langham; Shiro Fujita; Richard J Howard
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

Review 9.  VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis.

Authors:  Clarisse Eveno; Marc Pocard
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

10.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.